Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Dose descriptor:
LD50
Value:
83 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Dose descriptor:
LC50
Value:
340 mg/m³ air

Acute toxicity: via dermal route

Endpoint conclusion
Dose descriptor:
LD50
Value:
23 mg/kg bw

Additional information

There are appropriate studies available for the acute toxicity of the oral and dermal route (similar to OECD guideline studies with acceptable deviations (no necropsy, limited reporting and without GLP) and for the inhalation of vapor (OECD guideline study with GLP).

Clinical signs observed were similar for all three routes and were described as tremors, tonic convulsions, salivation, hypoactivty, ataxia and prostration. As for the acute inhalation toxicity mortality occured within the time of exposure, i.e. 1 h or 4 h.

Justification for classification or non-classification

According to the criteria in Annex VI to 67/548/EEC data on the acute toxicity of butanenitrile, 2 -amino-2,3 -dimethyl warrant classification as "toxic" by the oral route and "very toxic" by the dermal route and inhalation of vapor.

According to the criteria in Annex I to the CLP regulation data on the acute toxicity of butanenitrile, 2 -amino-2,3 -dimethyl warrant classification in Category 1 for acute inhalation toxicity (vapor) and acute dermal toxicity as well as Category 3 for acute oral toxicity